Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Anxiety Disorders × Niacin × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Skin Neoplasms 1 Neoplasms 1 Depression 1 Anxiety Disorders 1

Interventions

Surveys and Questionnaires 4 Psilocybin 2 Ketamine 2 Ultraviolet Therapy 1 Self-Help Groups 1 Relaxation Therapy 1 Psychotherapy 1 Psychosocial Intervention 1 Propranolol 1 Niacin 1 N-Methyl-3,4-methylenedioxyamphetamine 1 Minocycline 1 Midazolam 1 Melatonin 1 Interviews as Topic 1 Hormones 1 Donepezil 1 Dehydroepiandrosterone 1 Cognitive Behavioral Therapy 1 Cannabidiol 1 Autogenic Training 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

NYU Langone Health

Phase EARLY_PHASE1 Completed

29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡